Clinical Trials · NCT07622810
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Carnot Laboratories
- Enrollment
- 352
- Start date
- Sep 2026
- Locations
- 6 sites, Mexico
- Primary endpoint
- Percent Change in Body Weight From Baseline to Week 36